18th Annual Drug Discovery Symposium
The symposium is a key component of the education and outreach activities of Northwestern University's Center for Molecular Innovation and Drug Discovery. The symposium involves poster presentations by researchers working on drug discovery projects across a range of disease areas and features a keynote address. On November 13, 2013 the Center for Molecular Innovation and Drug Discovery (CMIDD) will bring together over 100 researchers from Northwestern University and other institutions in the Chicago area for the 18th Annual Drug Discovery Symposium. This is an opportunity for students, staff, faculty and members from industry to review the latest ground-breaking research in drug discovery. The symposium will feature a keynote address by Dr. Stephen Frye, Director for the Center for Integrative Chemical Biology and Drug Discovery and Fred Eshelman Distinguished Professor in the Eshelman School of Pharmacy at UNC, Chapel Hill. Prior to Dr. Frye's entrance into academia he worked at GlaxoSmithKline, where he most notably co-discovered the marketed product Avodart and created a department that discovered two FDA approved kinase inhibitor oncology therapies. His keynote address, titled, "Academic Drug Discovery and Chemical Biology: A Tale of Two Targets," will be followed by a scientific poster session and networking reception, involving posters presented by researchers hailing from NU and other Chicago institutions which traditionally include University of Illinois Chicago, Midwestern University and Northern Illinois University.
Additionally, each year CMIDD partners with Sigma-Aldrich to present two best poster awards to our top graduate and post-doctoral poster presenters. Don't forget to submit your abstract! The deadline has been extended to Thursday, November 7th at 10:00am.
RegistrationPlease go here to register your attendance or to submit your abstract.
Registration is now closed.
Call for AbstractsAbstract submissions should be submitted here: cmidd.northwestern.edu/symposium/form/abstract.
The deadline for submitting abstracts has passed.